ACR on Air Podcast

Logo

ACR on Air seeks to have informative conversations rheumatology professionals want to hear – ranging in topic from trends in clinical practice, to issues affecting rheumatology professionals, and the changing landscape of the rheumatology field. Tune in bi-weekly for new interviews and commentary that are sure to empower listeners to excel in their specialty.

Podcast Host

Jonathan Hausmann, MD

Our host, Jonathan Hausmann, MD, is a pediatric and adult rheumatologist at Massachusetts General Hospital and Boston Children’s Hospital. He is also an Assistant Professor of Medicine at Harvard Medical School. His research interests include autoinflammatory diseases, health technology, and medical education. Connect with Dr. Hausmann on Twitter (@hausmannMD).

 

Episodes

New episodes will be available twice a month on Tuesdays.

Episode 78 – Lyme Arthritis

Episode 77 – Lung Disease in Systemic Sclerosis

Episode 76 – Ultrasound Use in Rheumatology

Episode 75 – Practicing Pediatric Rheumatology in Southeast Asia

Episode 74 – Managing Osteoporosis

Episode 73 – Immune Related Adverse Events of Checkpoint Inhibitors

Browse previous episodes in the ACR on Air archive.

Episode Show Notes

Internationally renowned Lyme disease clinician and researcher, Allen Steere, MD, joins us for a discussion on Lyme arthritis. Dr. Steere explains the history of this disease, the historical identification of the borrelia spirochete which causes it, how Lyme arthritis manifests and presents (including why severity can be vary greatly in patients) and explore the current challenges in its diagnosis. We also cover treatment and antibiotic therapies for the disease, what post-treatment syndromes are, how to treat them and how understanding Lyme arthritis has improved our knowledge of other diseases, such as rheumatoid arthritis.

Allen Steere, MD

Allen Steere, MD – Allen Steere, MD, is a physician scientist who is internationally recognized for his studies of Lyme disease. Dr. Steere's medical school and residency were at Columbia University's College of Physicians and Surgeons and at St. Luke's Hospital in New York, a Columbia affiliate. From 1973–1975, he served in the Epidemic Intelligence Service at the Centers for Disease Control. In 1976, while a post-doctoral fellow at Yale, his training at the CDC was important in evaluating a cluster of children with arthritis in Lyme, Connecticut. Evaluation of this cluster led to the identification and description of Lyme arthritis. During his faculty period at Yale and subsequently at Tufts, he detailed the clinical features of Lyme disease, identified the spirochetal etiology of the infection in human patients, developed serologic, culture and PCR tests for diagnosis, conducted antibiotic trials, and was principal investigator of the SmithKline Beecham Phase III Lyme disease vaccine trial.

Dr. Steere currently serves as Professor of Medicine at Harvard Medical School and Director of Translational Research in Rheumatology at Massachusetts General Hospital, where he studies basic pathologic features of Lyme disease and rheumatoid arthritis. He has been particularly interested in understanding post-infectious Lyme arthritis. These patients develop pathology in affected joints that is like that seen in rheumatoid arthritis. In addition, he is currently working to translate his years of experience with infection and immunity in Lyme arthritis to the study of rheumatoid arthritis (RA). He and his colleagues have shown that Prevotella copri, a gut microbe, is an immune-relevant bacterium in RA. They are continuing to identify microorganisms that are a part of the normal flora in the bowel which stimulate immune responses that may affect joints in this disease.

He and his colleagues see patients with Lyme arthritis or rheumatoid arthritis weekly in the clinic. In both diseases, they are researching basic immune abnormalities, knowledge of which may lead to improved diagnosis and treatment of these diseases.

Don’t forget to like, share, and subscribe!

Submit Show Feedback

Expert researcher and clinician, Elana J. Bernstein, MD, MSc, is our guest this week as we dive into lung disease brought on by systemic sclerosis (SS). We discuss symptoms, diagnosis, and how systemic sclerosis affects the lungs, including pulmonary hypertension and interstitial lung disease. Dr. Bernstein, who has dedicated her career to improving patient outcomes in systemic sclerosis, explains her approach to screening for lung disease, plus the latest research and questions that need to be answered.

Elana J. Bernstein, MD, MSc

Elana J. Bernstein, MD, MSc – Elana J. Bernstein, MD, MSc, is Florence Irving Associate Professor of Medicine in the Division of Rheumatology at Columbia University Vagelos College of Physicians and Surgeons and Director of the Columbia University Scleroderma Center. Dr. Bernstein graduated summa cum laude from Amherst College and was inducted into the Alpha Omega Alpha medical honor society while a medical student at the Mount Sinai School of Medicine. She completed her medicine residency at the Massachusetts General Hospital and her rheumatology fellowship at Hospital for Special Surgery. Dr. Bernstein’s research focuses on lung disease in systemic sclerosis, post-lung transplant outcomes of adults with systemic autoimmune rheumatic diseases, and the relationship between autoimmunity and interstitial lung disease. Dr. Bernstein has received grants from the National Institutes of Health, Department of Defense, Rheumatology Research Foundation, and the Arthritis Foundation to study lung disease in systemic sclerosis.

Don’t forget to like, share, and subscribe!

Submit Show Feedback

Join us this week as our host, Jonathan Hausmann, MD, meets with a truly influential woman in the medical field, Elizabeth Ang, MBBS, MMed, MRCPCH, being one of the first pediatric rheumatologists in the Southeast Asian region to receive pediatric rheumatology training and is the Co-Convenor of the Paediatric Rheumatology Special Interest Group of APLAR (Asia Pacific League of Associations for Rheumatology). Beyond this, and so that children with rheumatic disease in the region can be diagnosed and treated, Dr. Ang trains local doctors and shares her knowledge and experience with them in Cambodia, Vietnam, Indonesia, and Myanmar. In this episode, she, and Dr. Hausmann discuss Singapore’s healthcare system, access to biologics, cultural barriers to treatment and more.

Minna Kohler, MD, RhMSUS

Minna Kohler, MD, RhMSUS – Minna Kohler, MD, RhMSUS, is the founder and director of the Rheumatology Musculoskeletal Ultrasound (MSKUS) Program at Massachusetts General Hospital. She completed a clinical/research rheumatology fellowship at Yale University School of Medicine. Prior training includes 3 years of general surgery residency, 2 years of the NIH-sponsored fellowship in Image-Guided Therapy in the Department of Radiology at Brigham and Women's Hospital, and internal medicine residency at Lahey Clinic. Dr. Kohler received diagnostic/interventional MSKUS training in the Yale MSKUS program for surgeons in the Department of Orthopaedics/Rehabilitation. She developed the MGH rheumatology ultrasound training curriculum and actively teaches MSKUS to MGH Rheumatology, IM, and Emergency Departments, Spaulding PM&R residents, and Harvard medical students. Dr. Kohler serves as key faculty for MGH rheumatology and the Spaulding PM&R residency programs (rotation director for rheumatology and ultrasound). She also serves as adjunct faculty to the MGH CURE (Center for Ultrasound Research Education) in the Department of Emergency Medicine. Dr. Kohler is a graduate of the USSONAR (Ultrasound School of North American Rheumatologists) program and serves as a faculty mentor for training ultrasound to rheumatologists nationally. She is the lead co-director for the Harvard MSKUS CME course and has been a pioneer in promoting ultrasound training through the American College of Rheumatology (MSKUS Education and RhMSUS certification exam subcommittees).

Don’t forget to like, share, and subscribe!

Submit Show Feedback

Join us this week as our host, Jonathan Hausmann, MD, meets with a truly influential woman in the medical field, Elizabeth Ang, MBBS, MMed, MRCPCH, being one of the first pediatric rheumatologists in the Southeast Asian region to receive pediatric rheumatology training and is the Co-Convenor of the Paediatric Rheumatology Special Interest Group of APLAR (Asia Pacific League of Associations for Rheumatology). Beyond this, and so that children with rheumatic disease in the region can be diagnosed and treated, Dr. Ang trains local doctors and shares her knowledge and experience with them in Cambodia, Vietnam, Indonesia, and Myanmar. In this episode, she, and Dr. Hausmann discuss Singapore’s healthcare system, access to biologics, cultural barriers to treatment and more.

Minna Kohler, MD, RhMSUS

Minna Kohler, MD, RhMSUS – Minna Kohler, MD, RhMSUS, is the founder and director of the Rheumatology Musculoskeletal Ultrasound (MSKUS) Program at Massachusetts General Hospital. She completed a clinical/research rheumatology fellowship at Yale University School of Medicine. Prior training includes 3 years of general surgery residency, 2 years of the NIH-sponsored fellowship in Image-Guided Therapy in the Department of Radiology at Brigham and Women's Hospital, and internal medicine residency at Lahey Clinic. Dr. Kohler received diagnostic/interventional MSKUS training in the Yale MSKUS program for surgeons in the Department of Orthopaedics/Rehabilitation. She developed the MGH rheumatology ultrasound training curriculum and actively teaches MSKUS to MGH Rheumatology, IM, and Emergency Departments, Spaulding PM&R residents, and Harvard medical students. Dr. Kohler serves as key faculty for MGH rheumatology and the Spaulding PM&R residency programs (rotation director for rheumatology and ultrasound). She also serves as adjunct faculty to the MGH CURE (Center for Ultrasound Research Education) in the Department of Emergency Medicine. Dr. Kohler is a graduate of the USSONAR (Ultrasound School of North American Rheumatologists) program and serves as a faculty mentor for training ultrasound to rheumatologists nationally. She is the lead co-director for the Harvard MSKUS CME course and has been a pioneer in promoting ultrasound training through the American College of Rheumatology (MSKUS Education and RhMSUS certification exam subcommittees).

Don’t forget to like, share, and subscribe!

Submit Show Feedback

Bone health may not be first on the mind when discussing rheumatology; however, Marcy B. Bolster, MD, believes it plays a vital role in caring for ‘the whole patient’. As such, Dr. Bolster’s innovative contributions to the field of osteoporosis cannot be overstated. In this episode, we discuss the role of the rheumatologist in helping to prevent or treat osteoporosis, how often it’s under-recognized, plus the services she created to help identify, diagnose, and treat the condition among patients.

Marcy B. Bolster, MD

Marcy B. Bolster, MD – Marcy B. Bolster, MD, is a Professor of Medicine at Harvard Medical School. She is the Director of the Rheumatology Fellowship Training Program in the Division of Rheumatology, Allergy and Immunology at the Massachusetts General Hospital (MGH). She sees patients in the Rheumatology and Endocrine Associates Outpatient Clinics. She led the efforts to create a Fracture Liaison Service at MGH and served as the Medical Lead from 2014–2021. She sees patients in the MGH Endocrine Clinic for Osteoporosis, and the MGH Rheumatology fellows rotate through this clinic for an enriched training experience in osteoporosis and bone health management.

Related Links:

Don’t forget to like, share, and subscribe!

Submit Show Feedback

Subscribe & Rate

Subscribe to our podcasts in your favorite podcast listening platform, and they’ll notify you when new episodes are available. Like what you hear? Don’t forget to leave a review!

 

Podcast Feedback

We love to hear from our listeners. Tell us how we are doing.

We use cookies on our website to improve our service to you and for security purposes. By continuing to use our site without changing your browser cookie settings, you agree to our cookie policy and the use of cookies. See ACR Policies